局部晚期非小细胞肺癌放化疗后早期整体纵向应变变化检测
这项前瞻性观察队列研究纳入34例局部晚期非小细胞肺癌患者,在放化疗前后多模态评估心功能。结果显示整体纵向应变(GLS)和射血分数(EF)从基线至治疗后1个月和3个月进行性下降,GLS与EF下降强相关,提示GLS减低是放化疗后早期心脏毒性征象。
要点
- 放化疗后GLS进行性下降,是早期心脏毒性的敏感征象。
- GLS与EF下降强相关,支持GLS用于监测心功能。
- 随访中23.5%患者出现心律失常,需关注心脏事件。
核心结论
- GLS减低是局部晚期非小细胞肺癌放化疗结束后出现的早期征象。
研究设计与样本
- 前瞻性观察性队列研究,初步分析纳入34例局部晚期非小细胞肺癌患者,平均年龄69.5岁,中位随访27.8个月。
- 治疗前完成血液样本、心电图、经胸超声心动图(TTE)和心脏磁共振检查,治疗期间每周心电图和心脏标志物检测,放化疗结束后1个月和3个月复查心电图和TTE。
- 放疗中位总剂量60 Gy常规分割,所有患者接受同步放化疗,65%为铂类方案。
诊断标准与关键数值
- GLS和EF从基线至放化疗后1个月和3个月进行性下降。
- GLS与EF下降强相关(1个月时p=0.034;3个月时p=0.018)。
- 8例患者(23.5%)在放化疗后平均15.8个月随访时发生心律失常。
临床应用与阅片要点
- 对局部晚期非小细胞肺癌放化疗患者,应在治疗前及治疗后1、3个月行TTE并测量GLS,以早期发现心功能减退。
- GLS下降可能早于EF下降,阅片时应关注GLS变化并在报告中提示临床。
局限性
- 初步分析样本量小(34例),为中位随访27.8个月的观察性研究,结论需未来研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Chemoradiation is the standard treatment in patients with locally advanced non-small-cell lung cancer (LA-NSCLC), and thanks to the recent combination with immunotherapy, median survival has unexpectedly improved. This study aims to evaluate early changes in cardiac function after chemoradiotherapy (CRT) in LA-NSCLC by multimodal use of advanced imaging techniques.
MATERIALS AND METHODS: This is a prospective, observational cohort study. At the beginning of combined treatment, screening tests including blood samples, electrocardiogram (ECG), echocardiographic examination (TTE), and cardiac magnetic resonance were performed in all patients with LA-NSCLC. ECG and cardiac marker assays were performed weekly during treatment. ECG and TTE were performed at month 1 (M1) and month 3 (M3) after the end of CRT.
RESULTS: This preliminary analysis included thirty-four patients with a mean age of 69.5 years. The median follow-up was 27.8 months. 62% of patients were in stage IIIA. Radiation therapy was delivered with a median total dose of 60 Gy with conventional fractionation. All patients were treated with concurrent CRT, and 65% of cases were platinum-based therapy. Global longitudinal strain (GLS) and ejection fraction (EF) progressively decreased from baseline to M1 and M3. There was a strong correlation between GLS and EF reduction (at M1: p = 0.034; at M3: p = 0.018). Cardiac arrhythmias occurred in eight patients (23.5%) at a mean follow-up of 15.8 months after CRT.
CONCLUSIONS: Reduction in GLS is an early sign occurring after the end of CRT for LA-NSCLC. Future studies are needed to identify variables that can increase the risk of cardiac events in this patient population to implement adequate damage prevention strategies.
引用
- Mega, Fiore, Carpenito, et al. Early GLS changes detection after chemoradiation in locally advanced non-small cell lung cancer (NSCLC). Radiol Med. 2022. PMID: 36208384. doi:10.1007/s11547-022-01557-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。